First Tracks Biotherapeutics

(NASDAQ) TRAX

Current Price$18.20

Market CapN/A

Since IPO (2026)-19%

5 YearN/A

1 YearN/A

1 Month-14%

First Tracks Biotherapeutics Financials at a Glance

Market Cap

N/A

Revenue (TTM)

N/A

Net Income (TTM)

N/A

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

5.07 (High)

Dividend

$0.00

Beta (Volatility)

5.07 (High)

Price

$18.20

Volume

536,153.959

Open

$15.24

Price

$18.20

Volume

536,153.959

Open

$15.24

Previous Close

$18.20

Daily Range

$14.90 - $18.42

52-Week Range

$14.72 - $26.80

Estimated Earnings Date

N/A

Dividend

$0.00

Beta (Volatility)

5.07 (High)

Price

$18.20

Volume

536,153.959

Open

$15.24

Previous Close

$18.20

Daily Range

$14.90 - $18.42

52-Week Range

$14.72 - $26.80

Estimated Earnings Date

N/A

TRAX News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About First Tracks Biotherapeutics

Industry

Biotechnology

Sector

Health Care

Headquarters

San Diego, CA 92121, US

TRAX Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

Return on Capital

-40%

Return on Assets

-34%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

Volume

536.15K

Avg. Volume

406.21K

Financials (TTM)

Gross Profit

-$139.61M

Operating Income

-$179.01M

EBITDA

-$178.45M

Operating Cash Flow

-$142.93M

Capital Expenditure

-$87.00K

Free Cash Flow

-$143.01M

Cash & ST Invst.

$311.64M

Total Debt

$14.11M

First Tracks Biotherapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

N/A

Market Cap/Employee

N/A

Employees

104

N/A

Net Income

-$50.48M

N/A

EBITDA

-$52.69M

N/A

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$286.46M

N/A

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-33.62%

N/A

Return on Invested Capital

-40.43%

N/A

Free Cash Flow

-$32.58M

N/A

Operating Cash Flow

-$32.56M

N/A

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

^GSPCS&P 500

^GSPCS&P 500$7,593.62+0.01%

^DJIDJI

^DJIDJI$51,525.18+0.02%

^IXICNASDAQ

^IXICNASDAQ$26,921.45+0.00%

BTCBitcoin

BTCBitcoin$63,111.00-0.04%

AAPLAAPL

AAPLAAPL$311.30+0.00%

AMZNAMZN

AMZNAMZN$254.69+0.02%

GOOGGOOG

GOOGGOOG$369.52+0.04%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$16.62-0.01%

STISolidion Technology

STISolidion Technology$22.71+3.51%

BBBlackBerry

BBBlackBerry$10.34+0.02%

TAT&T

TAT&T$22.77-0.03%

FOXXFoxx Development

FOXXFoxx Development$5.25+0.84%

IBITiShares Bitcoin Trust

IBITiShares Bitcoin Trust$36.02-0.03%

NUNu Holdings

NUNu Holdings$12.12+0.04%

Questions About TRAX

What is the current price of First Tracks Biotherapeutics?

First Tracks Biotherapeutics is trading at $18.20 per share.

What is the 52-week range for First Tracks Biotherapeutics?

Over the past 52 weeks, First Tracks Biotherapeutics has traded between $14.72 and $26.80.

How much debt does First Tracks Biotherapeutics have?

First Tracks Biotherapeutics total debt is unavailable.

How much cash does First Tracks Biotherapeutics have on hand?

First Tracks Biotherapeutics does not have cash on hand data available.

What is First Tracks Biotherapeutics’s dividend yield?

First Tracks Biotherapeutics does not currently have a dividend yield.

First Tracks Biotherapeutics

First Tracks Biotherapeutics Financials at a Glance

TRAX News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About First Tracks Biotherapeutics

TRAX Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

First Tracks Biotherapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About TRAX

What is the current price of First Tracks Biotherapeutics?

What is the 52-week range for First Tracks Biotherapeutics?

How much debt does First Tracks Biotherapeutics have?

How much cash does First Tracks Biotherapeutics have on hand?

What is First Tracks Biotherapeutics’s dividend yield?

Premium Investing Services